Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms for Fibromyalgia in Peripheral Tissue Innervation
NCT01125423Phase 4Completed
- Sponsor
- Albany Medical College
- Start
- May 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of milnacipran in fibromyalgia (FM) (2 arms), sponsored by Albany Medical College. Primary endpoint: Neurological and pain assessments at 10 weeks. Started May 2010; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01125423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01125423.